Patent details

300663 Product Name: Turoctocog alfa

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300663
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2167526
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300663
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/13/888
Marketing Authorization Type:
EEA
Marketing Authorization Date:
15/11/2013
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
15/04/2014
First Marketing Authorization date:
15/11/2013
Grant date:
22/09/2016
Activation date:
11/07/2028
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
15/04/2014
SPC/SPC Extension Expiration Date:
14/11/2028
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
15/04/2014
 
 

 

Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 BAGSVÆRD, Denmark (DK)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
15/04/2014
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
09/22
Publication date:
02/03/2022
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
39/16
Publication date:
28/09/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
2014/17
Publication date:
23/04/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/07/2028
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
22/09/2016 Outgoing Correspondence Decision grant 1 PDF /3/6/6/0/0/0400300663/docs/300663_7_outgoingcorrespondence20160926111235530.pdf
22/09/2016 SPC Documents Certificate SPC 1 PDF /3/6/6/0/0/0400300663/docs/300663_12_supplprotectioncertificate20160926111011675.pdf
28/10/2014 SPC Documents Annex SPC 20 PDF /3/6/6/0/0/0400300663/docs/300663_1_supplprotectioncertificate20201015102957601.pdf
28/10/2014 SPC Documents Accompanying letter SPC 2 PDF /3/6/6/0/0/0400300663/docs/300663_2_supplprotectioncertificate20201015102753212.pdf
28/10/2014 SPC Documents Annex SPC 4 PDF /3/6/6/0/0/0400300663/docs/300663_3_supplprotectioncertificate20201015102905697.pdf
29/07/2014 Outgoing Correspondence Outgoing Letter 1 PDF /3/6/6/0/0/0400300663/docs/300663_8_outgoingcorrespondence20140725.pdf
25/07/2014 SPC Documents Accompanying letter SPC 1 PDF /3/6/6/0/0/0400300663/docs/300663_6_supplprotectioncertificate20201015102411324.pdf
13/05/2014 Outgoing Correspondence Outgoing Letter 3 PDF /3/6/6/0/0/0400300663/docs/300663_11_outgoingcorrespondence20140513.pdf
17/04/2014 Outgoing Correspondence Outgoing Letter 1 PDF /3/6/6/0/0/0400300663/docs/300663_10_outgoingcorrespondence20140417.pdf
15/04/2014 SPC Documents Marketing Authorization SPC 3 PDF /3/6/6/0/0/0400300663/docs/300663_0_supplprotectioncertificate20201015101407829.pdf
15/04/2014 SPC Documents Summary of the characteristics of the product 14 PDF /3/6/6/0/0/0400300663/docs/300663_4_supplprotectioncertificate20201015101836547.pdf
15/04/2014 SPC Documents Annex SPC 1 PDF /3/6/6/0/0/0400300663/docs/300663_5_supplprotectioncertificate20201015101306034.pdf
15/04/2014 Application Form First filed application form 3 PDF /3/6/6/0/0/0400300663/docs/300663_9_applicationform20140415.pdf